Trials / Completed
CompletedNCT00152373
Double-blind, Placebo-controlled Study of Levetiracetam in Adults With POS
A Double-blind, Placebo-controlled, Randomized Study: 16-week Evaluation of the Efficacy and Safety of Levetiracetam (LEV) as add-on Therapy in Adults and Adolescents Older Than 16 Years Suffering From Partial Seizures.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 192 (planned)
- Sponsor
- UCB Pharma · Industry
- Sex
- All
- Age
- 16 Years – 70 Years
- Healthy volunteers
- —
Summary
clinical efficacy and safety of Levetiracetam as add-on therapy in adult Chinese subjects with partial seizures.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Levetiracetam |
Timeline
- Start date
- 2004-07-01
- Primary completion
- 2005-05-01
- Completion
- 2005-05-01
- First posted
- 2005-09-09
- Last updated
- 2013-12-03
Source: ClinicalTrials.gov record NCT00152373. Inclusion in this directory is not an endorsement.